The EU Commission conditionally clears a merger in the pharmaceutical sector (AbbVie / Allergan)

On 10 January 2020, the European Commission approved AbbVie’s acquisition of its rival Allergan, subject to the divestment of one of Allergan’s pipeline inflammatory bowel

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • Van Bael & Bellis (Brussels)

Quotation

Porter Elliott, The EU Commission conditionally clears a merger in the pharmaceutical sector (AbbVie / Allergan), 10 January 2020, e-Competitions January 2020, Art. N° 93240

Visites 118

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues